A S Novo Insider Profile
11 Followers
A S Novo, Ten Percent Owner at Hemab Therapeutics Holdings, Inc., holds 4.18M shares in Hemab Therapeutics Holdings, Inc. (Ticker: COAG), holds 3.88M shares in Avalyn Pharma Inc (Ticker: AVLN), holds 3.69M shares in MapLight Therapeutics, Inc. (Ticker: MPLT).
A S Novo Hemab Therapeutics Holdings, Inc. (COAG)Ten Percent Owner
Hemab Therapeutics Holdings, Inc. (COAG)
Ten Percent Owner
Ranked #64,058 out of 109,106 Corporate Insiders
Profitable Transactions
39 out of 76 Profitable Transactions
Average Return
-1.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that A S Novo holds in companies
Most Profitable Insider Trade
Stock:
Alder Biopharmaceuticals
(ALDR)
(ALDR)
Rating:Informative Buy
Date:May 13, 2014 - May 13, 2015
Return:+241.70%
The most profitable trade made by A S Novo
A S Novo's Trading History
Hemab Therapeutics Holdings, Inc.
May 06, 2026
Ten Percent Owner
Uninformative Buy
―
$153.55M
IVERIC bio
Dec 16, 2016
―
Informative Sell
17.59M
$196.17M
KalVista Pharmaceuticals
Oct 12, 2017
―
Informative Sell
26.27M
$78.35M
Apollo Endosurgery
Jul 26, 2017
―
Informative Sell
345.66K
$14.57M
Corvus Pharmaceuticals
Jul 09, 2020
Ten Percent Owner
Informative Sell
8.16M
$17.42M
Entasis Therapeutics Holdings
Oct 01, 2018
―
Uninformative Buy
―
$4.78M
Milestone Pharmaceuticals
Nov 27, 2019
SEE REMARKS, Ten Percent Owner
Informative Sell
3.84M
$2.10M
Morphic Holding
Jul 01, 2019
―
Informative Buy
10.00M
$150.76M
Mirum Pharmaceuticals
Jul 23, 2019
Ten Percent Owner
Uninformative Buy
―
$218.40M
Obsidian Therapeutics
Feb 19, 2021
Ten Percent Owner
Informative Sell
5.29M
$37.52M
Nkarta
Jul 16, 2020
Ten Percent Owner
Informative Buy
10.00M
$7.71M
Inozyme Pharma
Feb 01, 2021
―
Informative Sell
7.88M
$8.78M
Checkmate Pharmaceuticals
Feb 25, 2022
―
Informative Sell
23.02K
$22.70M
Harmony Biosciences Holdings
Aug 25, 2020
Ten Percent Owner
Informative Buy
3.18M
$178.51M
Spruce Biosciences
Mar 25, 2024
Ten Percent Owner
Informative Sell
348.77K
$126.01M
Praxis Precision Medicines
Oct 21, 2020
Ten Percent Owner
Uninformative Buy
―
$688.96M
Aligos Therapeutics
Oct 22, 2020
Ten Percent Owner
Uninformative Buy
―
$14.54M
Eargo
Oct 22, 2020
―
Informative Buy
2.70M
$2.28M
Damora Therapeutics
Nov 04, 2020
Ten Percent Owner
Informative Buy
5.00M
$51.05M
Edgewise Therapeutics
Sep 16, 2022
Ten Percent Owner
Informative Buy
5.00M
$249.24M
OnKure Therapeutics
Jun 23, 2023
Ten Percent Owner
Informative Sell
709.00K
$9.79M
Verve Therapeutics
Jun 22, 2021
―
Uninformative Buy
―
$8.83M
Cyteir Therapeutics
Jul 20, 2023
―
Informative Sell
280.24K
$10.60M
Minerva Surgical
Oct 27, 2021
Ten Percent Owner
Uninformative Buy
―
―
IO Biotech
Jul 26, 2024
Ten Percent Owner
Informative Sell
98.77K
$43.54K
Arcellx Inc
Feb 09, 2022
―
Uninformative Buy
―
$462.22M
Bolt Biotherapeutics
Jul 15, 2022
Ten Percent Owner
Informative Sell
1.60M
$13.52M
Disc Medicine
Jun 28, 2023
Ten Percent Owner
Informative Sell
57.63M
$72.09M
Metagenomi, Inc.
Feb 15, 2024
Ten Percent Owner
Informative Buy
13.03M
$1.97M
MapLight Therapeutics, Inc.
Oct 30, 2025
Ten Percent Owner
Informative Buy
16.20M
$39.70M
Avalyn Pharma Inc
May 05, 2026
Ten Percent Owner
Uninformative Buy
―
$115.22M
Tobira Therapeutics
Jul 13, 2016
―
Informative Sell
709.76K
$104.02M
Flexion Therapeutics
Jun 22, 2015
―
Informative Sell
3.09M
$19.45M
CoLucid Pharmaceuticals
Sep 13, 2016
―
Informative Buy
2.00M
$142.21M
HTG Molecular Diagnostics
Aug 25, 2017
Ten Percent Owner
Informative Sell
2.08M
―
Inogen
Jun 03, 2021
Ten Percent Owner
Informative Sell
38.98M
$10.58M
Alder Biopharmaceuticals
May 13, 2014
―
Uninformative Buy
―
$60.44M
Nevro Corp
Nov 13, 2014
―
Uninformative Buy
―
$12.82M
ZS Pharma
Jun 23, 2014
―
Uninformative Buy
―
$70.34M
Otonomy
Aug 20, 2014
―
Informative Buy
243.04K
$250.13K
Akebia Therapeutics
Mar 26, 2014
SEE REMARKS, Ten Percent Owner
Informative Buy
3.10M
$1.41M
Biomimetic Therapeutics
―
―
―
―
List of latest transactions for each holding click on a transaction to see A S Novo's performance on stock
You May Also Like
A S Novo insider profile FAQ
What is the percentage of profitable transactions made by A S Novo?
The percentage of profitable transactions made by A S Novo is 51%.
What is the average return per transaction made by A S Novo?
The average return per transaction made by A S Novo is -1.10%.
What stocks does A S Novo hold?
A S Novo holds: COAG, ISEE, KALV, APEN, CRVS, ETTX, MIST, MORF, MIRM, OBX, NKTX, INZY, CMPI, HRMY, SPRB, PRAX, ALGS, EAR, DMRA, EWTX, OKUR, VERV, CYT, UTRS, IOBTQ, ACLX, BOLT, IRON, MGX, MPLT, AVLN, TBRA, ~FLXN, CLCD, HTGMQ, INGN, ALDR, NVRO, ZSPH, OTIC, AKBA, BMTI stocks.
What was A S Novo’s latest transaction?
A S Novo latest transaction was an Uninformative Buy of ―.
What was A S Novo's most profitable transaction?
A S Novo’s most profitable transaction was an Informative Buy of ALDR stock on May 13, 2014. The return on the trade was 241.70%.
What is A S Novo's role in Hemab Therapeutics Holdings, Inc.?
A S Novo's role in Hemab Therapeutics Holdings, Inc. is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.